Abstract
We studied the sera of 36 patients with lupus anticoagulant and IgG antibodies against both phosphatidylserine and cardiolipin. Most sera also had IgG antibodies against other phospholipids: 97% against phosphatidylinositol, 91% against phosphatidylglycerol, and 82% against phosphatidylethanolamine. IgG2 was the predominant subclass against cardiolipin and phosphatidylserine; 35 of 36 patients (98%) had IgG2 against both phospholipids. Most patients also had the IgG1 subclass; 32 of 36 (89%) against cardiolipin and 25 of 36 (69%) against phosphatidylserine. IgG3 and IgG4 subclasses were present at very low concentrations and in only a minority of the sera. The antibody response against phosphatidylserine was characterized by significantly less IgG1 than was the response against cardiolipin (P less than 0.01), although the IgG2 responses against each phospholipid were not different. IgG subclasses were unrelated to any other aspect of the patients' history, including a history of thrombocytopenia or thrombosis, a positive antinuclear antibody test, or a diagnosis of systemic lupus erythematosus.
References
Aug 1, 1978·Clinical Immunology and Immunopathology·R D Sontheimer, J N Gilliam
Jan 1, 1987·Clinical Immunology and Immunopathology·D W BranchJ R Scott
Oct 1, 1987·Clinical Immunology and Immunopathology·E BonfaK B Elkon
Jan 22, 1988·JAMA : the Journal of the American Medical Association·D A TriplettC A Orr
Apr 1, 1988·Annals of the Rheumatic Diseases·A E GharaviK B Elkon
Apr 1, 1985·The Journal of Clinical Investigation·R A EisenbergW J Yount
Jan 1, 1985·Immunology Letters·R JefferisT W Wells
Nov 21, 1985·The New England Journal of Medicine·D W BranchE Hershgold
Nov 1, 1973·Clinical Immunology and Immunopathology·S KarpatkinG W Siskind
Mar 1, 1972·Arthritis and Rheumatism·P H SchurN Rothfield
Aug 16, 1980·Lancet·B G FirkinN Radford
Jan 31, 1981·Lancet·L O CarrerasA Van Assche
Mar 10, 1984·Lancet·P JungersJ F Bach
Nov 10, 1984·Lancet·E N HarrisG R Hughes
Mar 1, 1984·Archives of Internal Medicine·M Elias, A Eldor
Oct 8, 1983·British Medical Journal·M L BoeyG R Hughes
Apr 1, 1984·British Journal of Obstetrics and Gynaecology·W F LubbeG C Liggins
Jan 1, 1983·Journal of Clinical Immunology·R StevensD Heiner
Sep 1, 1980·The Journal of Clinical Investigation·P ThiagarajanL De Marco
Jul 24, 1980·The New England Journal of Medicine·G R SiberG Schiffman
Feb 1, 1980·Annals of Internal Medicine·J R MuehS I Rapaport
Citations
Aug 1, 1990·American Journal of Obstetrics and Gynecology·N S RoteD W Branch
Dec 3, 2014·The American Journal of Pathology·Yuan-Yuan WuElaine Y Lin
Nov 1, 1990·Clinical Immunology and Immunopathology·M M Ward, D S Pisetsky
Jul 10, 2003·Clinics in Laboratory Medicine·Neal S Rote, Bradley P Stetzer
Apr 2, 1999·American Journal of Reproductive Immunology : AJRI·W H KuttehR Silver
Apr 1, 1996·American Journal of Reproductive Immunology : AJRI·N S Rote
Sep 1, 1991·Scandinavian Journal of Immunology·U TiikkainenD Arthur
Feb 1, 1992·Lupus·I KrauseG R Hughes
Jun 1, 1992·Annals of the Rheumatic Diseases·K H SunC L Yu
Jan 30, 2004·American Journal of Reproductive Immunology : AJRI·Shelly Tartakover MatalonAsher Ornoy
Feb 1, 1994·Clinical and Experimental Immunology·J ArvieuxM G Colomb
Dec 1, 1992·Clinical and Experimental Immunology·S LoizouM J Walport